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Abstract
Background: Staphylococcus aureus is one of the most prevalent pathogens to cause mastitis in dairy cattle.
Intramammary infection of dairy cows with S. aureus is often subclinical, due to the pathogen’s ability to evade the
innate defense mechanisms, but this can lead to chronic infection. A sub-population of S. aureus, known as small
colony variant (SCV), displays atypical phenotypic characteristics, causes persistent infections, and is more resistant
to antibiotics than parent strains. Therefore, it was hypothesized that the host immune response will be different
for SCV than its parental or typical strains of S. aureus. In this study, the local and systemic immune protein
responses to intramammary infection with three strains of S. aureus, including a naturally occurring bovine SCV
strain (SCV Heba3231), were characterized. Serum and casein-depleted milk cytokine levels (interleukin-8, interferon-
g, and transforming growth factor-b1), as well as serum haptoglobin concentrations were monitored over time
after intramammary infection with each of the three S. aureus strains. Furthermore, comparative proteomics was
used to evaluate milk proteome profiles during acute and chronic phases of S. aureus intramammary infection.
Results: Serum IL-8, IFN-g, and TGF-b1 responses differed in dairy cows challenged with different strains of S.
aureus. Changes in overall serum haptoglobin concentrations were observed for each S. aureus challenge group,
but there were no significant differences observed between groups. In casein-depleted milk, strain-specific
differences in the host IFN-g response were observed, but inducible IL-8 and TGF-b1 concentrations were not
different between groups. Proteomic analysis of the milk following intramammary infection revealed unique host
protein expression profiles that were dependent on the infecting strain as well as phase of infection. Notably, the
protein, component-3 of the proteose peptone (CPP3), was differentially expressed between the S. aureus
treatment groups, implicating it as a potential antimicrobial peptide involved in host defense against S. aureus
intramammary infection.
Conclusions: Intramammary infection of dairy cattle with S. aureus causes an up-regulation of serum and milk
immune-related proteins, and these responses vary depending on the infecting strain.
Background
Mastitis, an inflammatory condition of the mammary
gland, typically arises as a result of intramammary infec-
tions. In lactating dairy cattle, mastitis results in consid-
erable monetary losses to the dairy industry due to
depressed milk yield and quality, reduced reproductive
performance, treatment, and pre-mature culling [1,2].
Staphylococcus aureus is a Gram-positive, opportunistic,
and contagious bacterium that is one of the most preva-
lent causes of mastitis in both humans and cattle [3].
Although infection can result in obvious clinical masti-
tis, S. aureus often evades the immune response result-
ing in a sub-clinical chronic infection that can persist
for the life of the animal [4]. Classically, S. aureus is
characterized as an extracellular pathogen [5]. However,
an increasing number of studies elude to its ability to
invade and survive within various host cell types, includ-
ing mammary epithelial cells, neutrophils, and macro-
phages [6-8]; this may contribute to its persistence in
various S. aureus-induced diseases [7]. Small colony
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endowed for persistent survival by residing in host cells
as they are characterized by slow-growth and atypical
colony morphology, and are often over-looked by stan-
dard laboratory assays [9]. It has been previously
demonstrated that SCVs can survive within professional
and non-professional phagocytic cells [8,10], are more
persistent than typical S. aureus strains [11], and are dif-
ficult to treat with conventional antibiotics [9].
Given that different S. aureus strains appear to utilize
unique infection and survival strategies, we hypothesized
that the host immune response will also vary in accor-
dance with the infecting strain. To elucidate potential
differences in host responses to S. aureus infection, the
present study was carried out to investigate the kinetic
response of key cytokines in serum and casein-depleted
milk, as well as serum haptoglobin over a 21-day period
following intramammary infection with three strains of
S. aureus. Additionally, a comparative proteomics plat-
form was used to resolve the proteome of casein-
depleted milk during acute and chronic phases of infec-
tion, and to identify differentially expressed proteins
with potential immunomodulating effects. The S. aureus
strains used for intramammary infection were: the SCV
Heba3231, a naturally occurring SCV isolated from a
dairy cow with history of chronic mastitis with atypical
phenotypic properties [10], the 3231 parent strain dis-
playing typical morphological and biochemical proper-
ties [10], and Newbould 305 (ATCC 29740), a teat skin
strain that causes clinical bovine mastitis [12,13] that is
frequently used as a model for studying S. aureus-
induced mastitis.
Results
Serum IL-8, IFN-g, TGF-b1, and haptoglobin response to S.
aureus intramammary infection
Lactating dairy cattle were challenged with one of three
S. aureus strains and the local and systemic host
immune responses were characterized by monitoring
cytokine kinetics and using a proteomics approach to
identify proteins that may play a role in host defense
(Figure 1). Significant IL-8 expression in the serum was
not evident for any of the challenge groups until day 14
post-infection (pi) (Figure 2A). Animals challenged with
Newbould 305 and Heba 3231 exhibited significantly
higher IL-8 expression on days 14 and 21 pi relative to
levels on day 0 (P < 0.01). Interestingly, animals chal-
lenged with Parent 3231 showed a significant decrease
in IL-8 expression on day 14 (P < 0.01), and no signifi-
cant change on day 21 pi, relative to day 0. Significant
differences in IL-8 expression between the three chal-
lenge groups were observed on days 14 and 21 pi, with
both Newbould 305 and Heba 3231 challenge groups
having significantly higher IL-8 expression than the
Parent 3231 group (P < 0.01). Milk IL-8 levels were not
statistically significantly different from baseline (day 0)
levels at any time during the study (data not shown).
Serum concentrations of IFN-g were significantly up-
regulated in the Newbould 305 challenge group during
days 1-6 pi relative to serum IFN-g levels at day 0 (P <
0.01) (Figure 2B). On day 21 pi however, all challenge
groups showed significant increases in IFN-g expression
compared to day 0 (Newbould 305 and Parent 3231, P <
0.05; Heba 3231, P < 0.01). Significant differences
between challenge groups occurred on days 1-6 pi,
whereby animals challenged with Newbould 305 had
significantly higher serum IFN-g levels compared to ani-
mals challenged with Heba 3231 (P < 0.01).
Serum TGF-b1 expression was significantly down-
regulated in animals challenged with Parent 3231
throughout days 1-6 and 14 pi relative to day 0 (P <
0.01) (Figure 2C). In contrast, on day 14 pi, the New-
bould 305 and Heba 3231 challenge groups had signifi-
cantly up-regulated expression (P < 0.01 and P < 0.05,
respectively). On day 21 pi, the Heba 3231 challenge
group was the only group to have significantly elevated
expression of TGF-b1c o m p a r e dt ol e v e l sa td a y0( P<
0.01). Significant differences in TGF-b1 expression
between the three challenge groups were observed on
day 14 pi, with Newbould 305 and Heba 3231 groups
having significantly higher TGF-b1l e v e l sc o m p a r e dt o
the Parent 3231 group (P < 0.01), and on day 21 pi,
with the Heba 3231 group having significantly higher
TGF-b1 expression compared to either Newbould 305
or Parent 3231 groups (P < 0.01). Milk TGF-b1l e v e l s
were not statistically significantly different from baseline
at any time during the study period (data not shown).
Analysis of serum revealed significant elevations in
haptoglobin concentrations within the first 24 hours pi
for all three challenge groups (P < 0.01) (Figure 2E);
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Figure 1 Flow chart of study outline.
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Page 2 of 13however, linear and orthogonal polynomial contrasts did
not reveal any significant differences in haptoglobin
responses between any of the challenge groups.
Milk IL-8, IFN-g and TGF-b1 response to S. aureus
intramammary infection
Significant changes in IL-8 and TGF-b1 expression were
not observed in casein-depleted milk for any of the chal-
lenge groups at any time, when compared to levels on
day 0 (data not shown). In contrast, IFN-g concentrations
were significantly increased in animals challenged with S.
aureus, but the response varied with the infection strain
(Figure 2D). For example, IFN-g concentrations were
increased in response to Newbould 305 on days 1-6 and
day 14 pi relative to levels on day 0 (P < 0.01), but not
day 21 pi. The Parent 3231 challenge group also showed
a significant increase in IFN-g expression on days 1-6 pi
(P < 0.05). No significant change in IFN-g expression was
seen for the Heba 3231 challenge group at any sampling
time. Significant differences between groups occurred on
days 1-6 and day 14 pi, where the Newbould 305
challenge group had higher IFN-g expression compared
to the Heba 3231 group (P < 0.05).
Milk proteome profiling following intramammary
infection with S. aureus
Milk proteome analyses by 2-dimensional gel electro-
phoresis (2DE) revealed 29 protein spots that were dif-
ferentially expressed on days 2 or 14 pi, relative to
expression on day 0 (P < 0.05) (Table 1), with up-regu-
lated expression occurring most frequently. In the New-
bould 305 challenge group, there were 12 and 1 protein
spots that were significantly induced on days 2 and 14
pi, respectively. In the group challenged with the Parent
3231 strain, 12 and 8 protein spots were significantly
induced on days 2 and 14 pi, respectively. Lastly, for the
Heba 3231 challenge group, no proteins were induced
on day 2 pi, however, 8 protein spots were significantly
induced on day 14.
Of the 29 spots that were differentially expressed dur-
ing the acute or chronic phases of infection, only 1 spot
was significantly differentially expressed over time and
A serumILͲ8 B serumIFNͲɶ C serumTGFͲɴ
D milkIFNͲɶ E Haptoglobin
Figure 2 Effects of intramammary infection with Newbould 305, Parent 3231, or Heba 3231 on cytokine and haptoglobin expression.
Least square mean of the log-transformed values ± standard error of the area under the curve for A) serum IL-8, B) serum IFN-g, C) serum TGF-
b, and D) milk IFN-g on days 1-6 pi are shown. Least square mean of the log-transformed values ± standard error are shown for day 14 and day
21 pi. Significantly increased or decreased cytokine levels relative to baseline (day 0) values are denoted by asterisks (P < 0.05* and P < 0.01**).
a,
b indicate significant differences in cytokine levels between treatment groups (P < 0.05). E) Serum haptoglobin least square mean of log-
transformed values ± standard error. Significant changes in serum haptoglobin concentration occurred over time for each challenge group (P <
0.01), but not at any individual time point, and no significant treatment differences were observed.
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Page 3 of 13between the S. aureus challenge groups based on the
FDR-adjusted P-value (P < 0.05). This spot, and four
other spots that were differentially expressed over time
and between the treatment groups based on their raw
P-values (P < 0.05), were excised and subjected to
protein sequencing by liquid chromatography and
tandem mass spectrometry (LC-MS/MS). Identification
of these protein spots and their expression patterns is
summarized in Table 2 and Figure 3. Three out of the 5
spots were identified as component-3 of the proteose
peptone (CPP3). Two of the spots corresponding to
CPP3 (spot # 39 and 235) were up-regulated in animals
challenged with Parent 3231 on day 2 and 14 pi (P <
0.05), as well as in the Heba 3231 challenge group on
day 14 pi, with treatment differences occurring on day
14 pi between Newbould 305 and Parent 3231 or Heba
3231 challenge groups (P < 0.05). In contrast, CPP3
(spot # 349) was only up-regulated in the Newbould 305
challenge group on day 2 pi (P < 0.01), with significant
treatment differences occurring between the Newbould
305 and Heba 3231 challenge groups (P < 0.05).
Discussion
The current study aimed to monitor the host immune
response to S. aureus intramammary infection using
three unique strains, and to identify potential candidates
for targeted therapies that may modulate the host defense
to S. aureus challenge. Intramammary infection with dif-
ferent strains of S. aureus resulted in variable cytokine
responses within the bovine mammary gland and circula-
tion, supporting our hypothesis that different strains of S.
aureus prompt the activation of host immune responses
that are unique to the infecting strain.
Typically, an increase in milk somatic cell count (SCC)
is indicative of an elevated and sustained inflammatory
response caused by intramammary infection. During
acute mastitis for example, neutrophil numbers in the
mammary gland increase dramatically, constituting >
90% of milk somatic cells [14], whereas somatic cells in
healthy glands contain < 22% neutrophils [15]. CXCL-8/
IL-8 is the main tissue-derived chemoattractant for neu-
trophils [16,17]; however, our observations demonstrated
Table 1 Change in milk protein expression on 2 and 14
days post-intramammary infection with different S.aureus
strains
Spot I.D. Trmt*Day LSM ± SEM p-vlaue Direction
11 P*14 0.03 ± 0.01 0.0205 ↑
Heba*14 0.02 ± 0.01 0.0382 ↑
12 P*2 0.05 ± 0.02 0.0127 ↑
13 P*2 0.02 ± 0.01 0.0206 ↑
Heba*14 0.02 ± 0.01 0.024 ↑
21 P*14 0.03 ± 0.01 0.0397 ↑
33 P*2 0.05 ± 0.02 0.0056 ↑
35 NB*2 0.02 ± 0.004 0.0041 ↑
Heba*14 0.01 ± 0.005 0.0467 ↑
39 (CPP3) P*2 0.02 ± 0.007 0.0476 ↑
P*14 0.01 ± 0.004 0.0032 ↑
Heba*14 0.01 ± 0.004 0.0154 ↑
45 NB*2 0.01 ± 0.004 0.0122 ↑
131 NB*2 0.01 ± 0.005 0.031 ↑
141 NB*2 0.04 ± 0.01 0.0296 ↑
212 P*2 0.01 ± 0.004 0.0038 ↑
Heba*14 0.01 ± 0.005 0.0408 ↑
220 P*2 0.04 ± 0.01 0.0214 ↑
Heba*14 0.01 ± 0.005 0.0304 ↑
222 NB*2 0.02 ± 0.009 0.0384 ↑
227 P*2 0.008 ± 0.003 0.0127 ↑
235 (CPP3) P*2 0.03 ± 0.01 0.0241 ↑
P*14 0.01 ± 0.006 0.0492 ↑
Heba*14 0.02 ± 0.006 0.0127 ↑
244 P*14 -0.008 ± 0.002 0.0016 ↓
250 NB*2 0.007 ± 0.003 0.0417 ↑
NB*14 0.01 ± 0.005 0.0535 ↑
251 P*2 0.04 ± 0.02 0.0449 ↑
(b-casein precursor) P*14 0.008 ± 0.002 0.0025 ↑
341 P*14 0.02 ± 0.004 0.0006 ↑
343 P*14 0.02 ± 0.009 0.0188 ↑
346 NB*2 0.02 ± 0.01 0.0331 ↑
349 (CPP3) NB*2 0.01 ± 0.004 0.0084 ↑
350 NB*2 0.02 ± 0.01 0.0423 ↑
351 P*2 0.04 ± 0.01 0.0079 ↑
P*14 0.02 ± 0.01 0.0467 ↑
352 P*2 0.01 ± 0.006 0.0411 ↑
354 NB*2 -0.02 ± 0.004 < 0.0001 ↓
(b-Lactoglobulin) NB*14 -0.02 ± 0.007 0.0105 ↓
Heba*14 0.01 ± 0.007 0.0459 ↑
T a b l e1C h a n g ei nm i l kp r o t e i ne x p r e s s i o no n2a n d1 4
days post-intramammary infection with different S.aureus
strains (Continued)
355 NB*2 0.01 ± 0.005 0.0481 ↑
358 NB*2 0.05 ± 0.02 0.0216 ↑
359 NB*2 0.01 ± 0.005 0.0494 ↑
P*2 0.01 ± 0.005 0.0474 ↑
NB, Newbould 305; P, Parent 3231; Heba, SCV Heba 3231
Trmt*Day denotes the treatment and day of the observed change in protein spot
CPP3, component 3 of the proteose peptone
Data are presented as the least square mean ± standard error of the mean
(LSM ± SEM).
Direction indicates the up-or down-regulation of the protein spot on day 2 or
14 pi, compared to baseline.
Spot I.D. number refers to protein spot number assigned by the Melanie
software. Spots that were excised and identified by LC-MS/MS are indicated in
parentheses.
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Page 4 of 13that the bovine IL-8 response did not always parallel the
somatic cell response during the different S. aureus intra-
mammary infections. Somatic cell scores were signifi-
cantly elevated throughout the study period, and peaked
during the acute phase (days 2-5 pi) in all challenge
groups (reported by Atalla et al., 2009 [18]), however, we
did not observe significant induction of IL-8 in the
casein-depleted milk at any point during the study
period, and it was only detected in the serum on days 14
and 21 pi in animals challenged with Newbould 305 and
Heba 3231. The lack of an IL-8 response in the milk is
consistent with two previously reported independent
studies carried out by Bannerman et al. (2004) and
Riollet et al. (2000b) [19,20], suggesting that bovine IL-8
Table 2 Identification of proteins differentially expressed in different S.aureus challenge groups 2 or 14 days post-
infection
Spot I.D. Protein NCBI Accession no. MS result
a Th. Mass (kDa)/pI
b Obs. Mass (kDa)/pI
b
39 Component PP3 2007376A 98; 13 15.3/5.98 16/6.5
235 Component PP3 2007376A 115; 13 15.3/5.98 15/7
251 b-casein precursor P02666 72; 8 25.1/5.26 20/7
349 Component PP3 2007376A 208; 39 15.3/5.98 19/6
354 b-lactoglobulin CAA32835 109; 11 20.3/4.85 15/8
aIon score is = 10*Log(P) where P is the probability that the observed match is a random event (ion scores > 47 are significant at p < 0.05);% coverage.
bTheoretical (Th.) and observed (Obs.) masses and isoelectric points (pI).
CPP3(349) ɴͲcaseinprec.
ɴͲLg CPP3(235)
CPP3(39)
CPP3(39) CPP3(235) CPP3(349)
ɴͲcaseinprecursor ɴͲlactoglobulin
Figure 3 Two-dimensional gel electrophoresis of milk proteins. Proteins were resolved on a 13 cm Immobiline DryStrip, pH 3-10, followed by
12.5% SDS-PAGE. Circled spots are significantly different in protein expression between treatment groups as well as on day 2 or 14 pi, relative to
day 0 values. Corresponding graphs detail the least square mean of the log transformed spot intensities ± SEM for each spot. Significant changes in
protein expression levels relative to baseline (day 0) are denoted by asterisks (P < 0.05* and P < 0.01**).
a,b significant differences in protein
expression between treatment groups on day 2 or 14 pi with raw p-values and FDR-adjusted p-values presented (P < 0.05).
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Page 5 of 13is not the only chemokine involved in trafficking neutro-
phils to the infected mammary gland. It is possible that
other chemoattractants, such as complement cleavage
factor 5a, IL-1b,T N F - a, CXCL1 and 3, and granulocyte-
macrophage colony stimulating factor (GM-CSF) pro-
duced by epithelial cells, macrophages and T cells, also
contribute to neutrophil trafficking to the mammary
gland during intramammary infection [21-23]. For
instance, neutrophil infiltration into the bovine mam-
mary gland may be mediated by IFN-g through the
mechanism described by McLoughlin et al. (2008) [8]
that involves CXC chemokines other than IL-8. Such
chemokines may include CXCL1 and CXCL3, which are
constitutively expressed in bovine milk [23]. In support
of this, it has been demonstrated that IL-8 and GM-CSF
are not active chemokines during lactation, whereas
other factors such as IL-1b and TNF-a a r ea c t i v ed u r i n g
any stage of lactation [22,24].
In the present study, IFN-g was found to be highly
expressed both locally, as indicated by levels in the milk,
and systemically during days 1-6 pi in animals chal-
lenged with Newbould 305, which parallels previously
reported results by Bannerman et al. (2004) [19]. Serum
IFN-g levels were significantly up-regulated in all chal-
lenge groups at day 21 pi compared to day 0. This find-
ing may be associated with the promotion of an
enhanced cell-mediated immune response that includes
neutrophil and macrophage activation.
During the chronic phase of infection, differences in
serum TGF-b1 expression between the three challenge
groups were observed with notable increases being
observed for the Parent 3231 and Heba 3231 groups.
Milk TGF-b1 did not significantly differ in response
between any of the challenge groups; however, a trend
towards altered TGF-b1e x p r e s s i o ni na n i m a l sc h a l -
lenged with Newbould 305 was observed, whereby the
cytokine levels reached a maximum at 48 hours pi
(approximately 4000 pg/ml, data not shown). This
observation is in line with a previous report of milk
TGF-b1 kinetics upon Newbould 305 challenge in dairy
cattle [25].
The role of TGF-b in the host response to intramam-
mary infection is uncertain because TGF-b is a pleiotro-
pic immunoregulatory cytokine, with both pro- and
anti-inflammatory functions, depending on the location
and activation state of the cells that it is interacting with
[25]. This is exemplified by the cytokine’sd u a la c t i o n s
on macrophages. For instance, TGF-b suppresses tissue
macrophage function and inflammation by down-regu-
lating the production of chemokines and cytokines such
as IFN-g [26], up-regulating the expression of IL-1
receptor antagonist [27], and suppressing the production
of cytotoxic reactive oxygen and nitrogen intermediates
[28,29]. In contrast, TGF-b has also been shown to
promote inflammation by inducing chemotaxis in
human peripheral blood monocytes [30,31], enhancing
their ability for transendothelial migration to sites of
infection [32], and up-regulating the transcription of
pro-inflammatory cytokines such as IL-1b and TNF-a.
Furthermore, TGF-b has been shown to be an impor-
tant factor for the differentiation of a subset of effector
Th cells known as Th17 cells, which elicit inflammatory
responses during certain pathogenic infections that are
not sufficiently dealt with by Th1 or Th2 immunity [33].
Lastly, regulatory cells including Tregs and M2 macro-
phages also produce TGF-b in humans. These cells help
to prevent the deleterious effects of prolonged or exces-
sive host immune responses [34,35], and this process
includes suppressing various components of the immune
response such as antigen presentation by antigen pre-
senting cells [36], and promoting tissue repair by
increasing the deposition of extracellular matrix at the
site of tissue injury, and promoting angiogenesis [37].
Since TGF-b was not observed locally in the present
study, it is unlikely that it was involved in repair of the
mammary gland epithelium.
T h e r ei se v i d e n c et os u g g e s tt h a tS. aureus may be
able to modulate the host immune response in part by
promoting TGF-b expression; this could be a mechan-
ism utilized by the Heba 3231 strain for example, to
promote its survival within the host. In support of this,
Staphylococcal superantigens (SAgs) have been demon-
strated to induce the production of TGF-b by initiating
the differentiation and expansion of Tregs that down-
regulate the inflammatory response [38-40]. Indeed,
TGF-b has been implicated in playing a role in immu-
nosuppression by up-regulating the expansion and/or
activation of anergic regulatory T cells in the presence
of S. aureus SAgs, which may disrupt class II MHC anti-
g e np r e s e n t a t i o nb yA P C s[ 4 1 ], limiting cell-mediated
immunity. Interestingly, this immunomodulatory
mechanism is also employed by Leishmania as a means
to suppress cell-mediated immunity and promote its
intracellular survival [42,43]. Lastly, it should be noted
that TGF-b expression may not necessarily denote its
level of bioactivity, since a study by Kehrl et al. (1986)
[44] demonstrated that human B cells largely express
inactive TGF-b in response S. aureus Cowan strain I.
Overall, haptoglobin concentrations increased with
time in all challenge groups during the first 6 days of
the study period, and declined to initial levels by days
14 and 21 pi. However, no significant differences in
serum haptoglobin levels were observed between the
challenge groups. This may have been due to the chosen
sampling times, as no samples were taken between days
6 and 14 pi. It has been previously demonstrated that
haptoglobin is up-regulated during the acute phase
response, and that it may be used to discriminate
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[45,46]. The findings in the present study indicate that
overall serum haptoglobin levels were not significantly
different between any of the challenge groups, suggest-
ing that haptoglobin is a sensitive marker of inflamma-
tion due to S. aureus but it lacks specificity to
discriminate the host response to the three different
strains of S. aureus.
It was previously demonstrated that two common
mastitis-causing pathogens, Escherichia coli and S. aur-
eus, elicit different immune responses and pathogenesis
[19]. Here, we demonstrate that the variability in
immune protein response is also strain-specific, at least
in the context of S. aureus. Further studies investigating
the profiles of other cytokines will add to the results of
the current study. Studying IL-17 and IL-6 for instance
w o u l dp r o v i d ei n s i g h ti n t ot h ei n v o l v e m e n to fT h 1 7
cells in S. aureus infections, as IL-17 is a Th17 cytokine
and IL-6, along with TGF-b supports the differentiation
of this Th subtype [47-49]. Furthermore, IL-6 is one of
the major signals for the induction of the acute phase
response [50], and may therefore compliment the pre-
sent haptoglobin data. Monitoring chemoattractive fac-
tors, especially those under the regulation of TGF-b (i.e.
IL-1b and TNF-a), would help delineate the pro- or
anti-inflammatory role of TGF-b in intramammary
infection with different strains of S. aureus. Although it
would have been interesting to measure IL-1-b and
TNF-a as well as other cytokines such as IL-4, IL-6, IL-
12, and IL-10 that regulate the differentiation of these
T-cell subpopulations, we had limited resources to carry
out the cytokine analysis, and felt that inclusion of these
cyctokies was beyond the scope of the current study as
the aim was to note differences in host responses to dif-
ferent S. aureus strains, not to determine whether TGF-
b is a pro- or anti-inflammatory cytokine.
In addition to seeing unique cytokine profiles in
response to the different strains of S. aureus, the present
study also found a number of milk proteins to be differ-
entially expressed at various time-points in response to
infection, including host defense proteins. Staphylococ-
cus aureus insult to the mammary gland causes an
inflammatory response that is characterized by an
increase in vascular permeability, allowing exudates con-
taining cells and proteins from the vasculature to enter
the mammary gland [50]. Additionally, resident and
recruited cells produce a number of proteins that target
the pathogen and contribute to the restoration of home-
ostasis [50]. Therefore, the proteome of the milk may
drastically change in response to pathogenic stimuli, and
analysis of these changes may offer insight into the host
response during mastitis. Indeed, the present study
demonstrated changes in the milk proteome during
intramammary infection with S. aureus.I no r d e rt o
a s s e s sp r o t e i ne x p r e s s i o ni nm i l kd u r i n gt h ea c u t ea n d
chronic phases of infection, samples were evaluated on
days 2 and 14 pi, respectively. Most proteins were up-
regulated following Newbould 305 and Parent 3231
challenges, especially on day 2 pi during the acute phase
of infection. On day 14 pi, the number of up-regulated
proteins was dramatically reduced in the Newbould 305
and Parent 3231 challenge groups, as compared to day 2
pi. Results from this study indicate that differences in
milk protein expression also occur as a result of intra-
mammary infection with different strains of S. aureus.
On day 2 pi for example, challenges with Newbould 305
and Parent 3231 induced 12 milk proteins each, relative
to day 0. In contrast, significant changes in milk protein
expression were not observed in response to challenge
with Heba 3231 at this time. On day 14 pi however, 8
milk proteins were induced by challenge with the Parent
3231 strain and only 1 protein was induced by New-
bould 305, whereas 8 proteins were significantly induced
by the Heba 3231 challenge. These results are indicative
of the acute pathogenic nature of the Parent 3231 and
Newbould 305 strains and the unique phenotypic prop-
erties of SCVs, which may elicit a milder host response
[ 1 8 ] .T h e ys u g g e s tah i g h l ya c t i v ei n i t i a lh o s tr e s p o n s e
to challenges with the Parent 3231 and Newbould 305
strains, then perhaps resolution or establishment of
chronic infection by day 14 pi. This corresponds with
the somatic cell score data from these same cows pre-
sented by Atalla et al. (2009) [18], whereby the number
of somatic cells in the milk during the chronic phase of
infection still remained significantly up-regulated relative
to day 0. Interestingly, we were not able to detect an
initial host response to the SCV strain, but the induc-
tion of protein expression was demonstrated on day 14
pi. This delayed and relatively low level of host response
corresponds to the ability of the Heba 3231 strain to
avoid recognition and persist within host cells [10].
Future studies should include later time points in order
to determine if Heba 3231 continues to up-regulate
milk protein expression.
Two of the five spots corresponded to the most abun-
dant milk proteins - b-casein precursor and b-lactoglo-
bulin. This finding is likely a result of incomplete
depletion of these highly abundant proteins. Nonethe-
less, the depletion protocol was found to be sufficient to
yield a comprehensive view of the milk proteome. Of
t h ef i v ep r o t e i ns p o t st h a tw e r es u b j e c t e dt oi d e n t i f i c a -
tion by LC-MS/MS, only one protein, CPP3 also known
as lactophorin, was implicated in host defense. Compo-
nent 3 of the proteose peptone is a phosphoglycoprotein
uniquely expressed in the mammary gland of lactating
d a i r yc a t t l ea n dc a nb ef o u n di nb o v i n em i l kw h e y .I t
has been previously suggested to have several functions
that include antimicrobial activity, inhibition of lipolysis,
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consists of seven polypeptide components, ranging in
molecular weight from 17 to 67 kDa [55,56]. In the 2DE
g e l s ,i to c c u r r e da tt h r e ed i f f e r e n tl o c a t i o n sr a n g i n gi n
mass from 15-21 kDa and isoelectric point (pI) from 6-7
(Figure 3), which may correspond to its various compo-
nents. In one study, the antimicrobial activity of CPP3
was investigated using a synthetic peptide called lacto-
phoricin consisting of the 113-135 region of C-terminal
of CPP3 [51]. Lactophoricin interacts with membrane
phospholipids and forms voltage-dependent channels.
Thus, it has been hypothesized that it may also be
involved in the pore forming of natural lipid bilayers
such as bacterial membranes [51,57]. Indeed, Campag-
na’s results demonstrated that this peptide has inhibi-
tory-growth effects on a number of Gram-positive and
Gram-negative bacteria, with a more pronounced inhibi-
tory effect on Gram-positive bacteria, including S. aur-
eus [51].
Conclusions
The present study demonstrates the complexity of the
host immune protein response to various strains of S.
aureus. Intramammary infection with different strains of
S. aureus, elicited unique host immune protein
responses, as indicated by differential expression of the
cytokines IL-8, TGF-b,a n dI F N - g in circulation and
IFN-g in casein-depleted milk. In general, cytokines dis-
played heightened responses in the serum compared to
the casein-depleted milk. Interestingly, the SCV strain,
Heba 3231, showed increased levels of serum IL-8, IFN-
g,a n dT G F - b occurring during the later stages of infec-
tion (day 21 pi). Whether this pattern of induction con-
tinues in later time points has yet to be determined.
Using a proteomic approach, we have also demonstrated
that intramammary infection with three different strains
of S. aureus elicits differential protein expression in
bovine milk during the acute and chronic phases of
infection. Intramammary infection with Newbould 305
and Parent 3231 strains resulted in pronounced induc-
tion of protein expression on day 2 pi, while the Heba
3231 strain elicited no protein induction at this time.
On day 14 pi, host protein activity was less pronounced
for animals challenged with Newbould 305 and Parent
3231 strains, while some induction occurred in animals
challenged with Heba 3231. Lastly, CPP3, a potential
antimicrobial peptide that is uniquely expressed in the
bovine mammary gland during lactation, appeared on
our 2DE gels as three different spots, which were differ-
entially expressed between the various S. aureus treat-
ment groups. These results demonstrate that different
strains of S. aureus affect the proteome of the milk in
different ways. Of specific interest was the unique
response to the SVC, Heba 3231 on day 21 pi.
Therefore, investigating these changes in protein expres-
sion at later stages of infection is warranted. Overall,
this study begins to shed light on the milk proteome
and the changes that are elicited by intramammary
infection with various strains of S. aureus and highlights
an antimicrobial peptide, CPP3, which may have novel
therapeutic potential.
Methods
Selection of animals
A detailed description of the selection criteria for cows
used for intramammary infection has been previously
described [18]. Briefly, healthy Holstein dairy cows (5
cows/treatment group) from the University of Guelph
dairy herd and housed in the Ponsonby Research Station
(Elora, Ontario, Canada) were selected for the studies
under the following criteria: 1) quarter milk samples
were negative for S. aureus; 2) quarter milk samples
contained ≤ 500 colony forming units (CFU) per ml of
potential udder pathogens, other than S. aureus,t h a t
were mostly found in mixed culture; and 3) quarter
milk samples had SCCs < 2 × 10
5 cells/ml. All cows
were in their mid-to late-lactation and in the second or
third trimester of gestation. They had no previous his-
tory of clinical mastitis and were in their first to fifth
lactations. Animals were house in a tie-stall barn and
fed a mixed ration formulated for the University dairy
herd and milked twice daily. The study was approved by
the University of Guelph Animal Care Committee.
S. aureus intramammary challenge
The S. aureus intramammary challenges were carried
out between January and May of 2007. A detailed
description of the preparation of S. aureus cultures and
intramammary challenge is described by Atalla et al.
(2009) [18]. Cows were randomly assigned to one of
three treatments and then challenged with either SCV
Heba3231, 3231 parent strain, or the Newbould 305.
Three quarters (right front, right hind, and left hind)
were infused with ~1 × 10
3 CFU/ml of bacteria sus-
pended in 5 ml of ice-cold pyrogen-free PBS through
the teat canal using a syringe fitted with a 1.5 inch teat
infusion canula. The left front quarter was infused with
5 ml of ice-cold pyrogen-free PBS, pH 7.4. The teats
were then massaged in a dorsal direction and dipped in
1% iodine teat dip.
Sample collection
For this study, milk samples were only collected from
the right hind quarter for analysis - the other two
infected quarters and the saline quarter were used for
sample collection by another group [18]. For collection,
the teat was dipped in 1% iodine teat dip just prior to
regular morning milking, fore-stripped by hand milking
and the first two streams of milk were discarded. The
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with gauze soaked in 70% isopropyl alcohol, and milk
samples were subsequently collected into sterile 50 ml
centrifuge tubes on day 0 before intramammary chal-
lenge, and days 1-6, 14, and 21 pi. Samples were kept at
4°C or on ice during transportation to the laboratory
where they were immediately processed at 4°C. For the
preparation of casein-depleted milk, whole milk samples
were centrifuged at 1500 g and 4°C for 30 min. The top
lipid layer was discarded and the remaining skim milk
was stored at -20°C until ultracentrifugation. For ultra-
centrifugation, milk samples were thawed at 4°C for 15-
17 hr, and centrifuged at 45,500 g at 4°C for 30 min.
The resulting casein-depleted milk was recovered and
stored at -20°C until used.
Approximately 10 ml of blood from the tail vein of
each cow was collected into vacutainers (SST Gel and
Clot Activator from BD Biosciences, Mississauga,
Ontario, Canada) on the mornings of days 0-6, 14, 21,
28, and 35 pi. The samples were kept at 20°C for a max-
imum of 1 hour during transportation from the animal
housing facility to the laboratory. Samples were then
c e n t r i f u g e da t1 2 0 0g at 20°C for 30 min to obtain sera
and stored at -80°C until used.
Analysis of IL-8, TGF-b1, and IFN-g in serum and casein-
depleted milk
Serum and milk cytokines were measured on days 0, 1,
2, 4, 6, 14, and 21 pi by ELISA. For IL-8, a commercially
available human IL-8 ELISAk i t( R & DS y s t e m sI n c . ,
Minneapolis, Minnesota, USA) was used to measure
bovine IL-8 in milk and serum samples according to the
manufacturer’s instructions with a slight modification.
The antibodies used in the kit have been previously vali-
dated to cross-react with bovine IL-8 [58]. As the manu-
facturer’s instructions were not optimized for use in
milk, the sample incubation time for the analysis of IL-8
in casein-depleted milk was increased to 20 hr at 4°C.
The inter- and intra-assay coefficients of variation for
serum were 6% and ≤ 3%, respectively, and for the milk
they were 11% and ≤ 3%, respectively. The limit of
detection for this assay was 0.4 pg/ml.
Serum and milk IFN-g concentrations were measured
using a commercially available bovine IFN-g ELISA kit
(Mabtech Inc., Cincinnati, Ohio, USA) according to the
manufacturer’s instructions. As the manufacturer’s
instructions were not optimized for use in milk, the
sample incubation time for the analysis of IFN-g in
casein-depleted milk was increased to 20 hr at 4°C. The
inter- and intra-assay coefficients of variation for serum
were 8% and < 4%, respectively, and for the casein-
depleted milk they were 6% and ≤6%, respectively. The
limit of detection for this assay was 9 pg/ml.
Lastly, a commercially available human TGF-b1E L I S A
kit (R&D Systems Inc.) that has been previously validated
to cross-react with bovine TGF-b1 by Ginjala and Pakka-
nen (1998) [59]. For activation of latent TGF-b in casein-
depleted milk, 0.1 ml of undiluted casein-depleted milk
was incubated with 0.1 ml of 2.5 N acetic acid/10 M urea
for 10 min. Then 0.1 ml of 2.7 N NaOH/1 M HEPES was
added to neutralize the reaction and the final solution
was diluted 4-fold with Reagent Diluent Concentrate
(R&D Systems, Inc.). Casein-depleted milk samples were
assayed according to the manufacturer’s instructions with
the exception of the sample incubation time, which was
increased to 20 hr at 4°C. For serum TGF-b1, serum
samples were activated and diluted 10-fold with Reagent
Diluent Concentrate (R&D Systems Inc.). Samples were
then assayed according to the manufacturer’si n s t r u c -
tions. The inter- and intra-assay coefficients of variation
for serum were 7% and ≤ 3%, respectively; for milk they
were 6% and ≤ 3%, respectively. The limit of detection
for this assay was 8 pg/ml.
Haptoglobin
Serum haptoglobin was quantified in samples collected
on days 0, 1, 2, 4, 6, 14, and 21 pi, at the University of
Guelph Animal Health Lab (Guelph, Ontario). Spectro-
photometric quantification was based on the method
developed by Makimura and Suzuki (1982) [60], which
utilizes differences in perox i d a s ea c t i v i t yi nf r e eh e m o -
globin versus hemoglobin/haptoglobin conjugate.
Milk proteome profiling by 2 D gel electrophoresis
For the preparation of milk for 2DE, casein-depleted
milk samples were subjected to b-lactoglobulin (b-Lac-
toglobulin) depletion by cyanogen bromide-activated
Sepharose 4B conjugation with b-Lactoglobulin. In
order to do this, a matrix was first prepared by washing
CNBr-activated Sepharose powder (GE Healthcare, Qué-
bec, Canada) with 200 ml of 1 mM HCl for every 1 g of
powder. The matrix was equilibrated with coupling buf-
fer (0.1 M NaHCO3 containing 0.5 M NaCl, pH 8.3) by
rotating on a sample mixer for 20 min at 20°C. The b-
Lactoglobulin (Sigma-Aldrich, Oakville, Ontario,
Canada) was dissolved in coupling buffer to a final con-
centration of 12 mg/ml b-Lactoglobulin-coupled gel
matrix. The dissolved b-Lactoglobulin solution and the
equilibrated gel medium were mixed for 2 hr at 20°C.
The reaction was quenched with 1 M ethanolamine (pH
8.0) for 2 hr at 20°C. The mixture was centrifuged, and
the supernatant was discarded without perturbing the b-
Lactoglobulin-coupled gel medium. The coupled med-
ium was washed with 0.1 M NaCl/HCl (pH 2) and then
equilibrated with water for 20 min at 20°C, centrifuged
for 1 min at 16,000 g to pellet the beads, and the
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The matrix was stored at 4°C in 20% ethanol until used.
For b-Lactoglobulin depletion, 1 × sample volume of
sodium acetate buffer (pH 4.6) was added to the sam-
ples, mixed, and centrifuged at 16,000 g for 30 min at 4°
C. The resulting supernatant was transferred to the
CNBr-activated Sepharose 4B beads conjugated with b-
Lactoglobulin, mixed on a rotating sample mixer for 20
min and centrifuged at 16,000 g to separate the b-Lacto-
globulin-conjugated beads. The resulting supernatants
were subjected to methanol-chloroform treatment to
precipitate proteins. First, 2 × the sample volume of
methanol and 1 × the sample volume of chloroform was
added to the samples and proteins were allowed to pre-
cipitate for 1 hr at -20°C. The samples were centrifuged,
the upper phase was discarded and another round of
methanol and chloroform was added to the remaining
samples and mixed. The samples were centrifuged and
the supernatants were discarded, and the resulting pro-
tein pellets were solubilized to a concentration of 200
μgp r o t e i n / 2 5 0μl in rehydration solution containing 8
M urea, 2% w/v CHAPS, 0.28% w/v DTT, 0.5% w/v IPG
buffer (GE Healthcare), and bromophenol blue. Protein
concentration was determined using a Nanodrop Spec-
trophotometer (Nanodrop Technologies, Wilmington,
Delaware, USA).
For 2DE proteome profiling, the casein-depleted and
b-Lactoglobulin-depleted milk samples were separated
in the first dimension by isoelectric focusing (IEF) on 13
cm Immobiline DryStrips (pH 3-10; GE Healthcare)
using the following protocol carried out at 20°C on an
Ettan IPGphor IEF system (GE Healthcare). Strip rehy-
dration was carried out for 2 hr then IEF was carried
o u ta t3 0Vf o r1 0h r ,1 0 0Vf o r1h r ,3 0 0Vf o r1h r ,
600 V for 1 hr, 1000 V for 1 hr, 3000 V for 1 hr, 4000
Vf o r2h r ,a n d8 0 0 0Vf o r2h ra t5 0μA/strip. The
strips were stored at -80°C until the second-dimension
separation. For separation in the second dimension,
strips were equilibrated for 15 min in equilibration buf-
fer containing 1.5 M Tris-HCl (pH 8.8), 6 M Urea, 30%
v/v glycerol, 2% w/v SDS, bromophenol blue, and 1% w/
v DTT. The strips were cast in 0.5% w/v agarose on
12% SDS-PAGE gels and run at 30 mA/gel. Protein
migration was stopped when the dye front reached the
bottom of the gels, and fixation was carried out over-
night in 50% methanol and 10% acetic acid. The gels
were stained with RAPIDstain (G-Biosciences, Maryland
Heights, Missouri, USA) following the manufacturer’s
instructions and scanned using ImageScanner (GE
Healthcare).
Gels were analyzed using Melanie 7.0 software (Gene-
Bio, Geneva, Switzerland). Protein spot intensities were
automatically background-subtracted on a spot basis,
whereby the lowest 10
th percentile pixel value on the
spot boundary was excluded from all other pixel values
within the spot boundary. Spots were matched based on
a hierarchical matching structure, as suggested in the
Melanie 7.0 user manual.
The five protein spots of interest on the 2DE gels
were excised using a scalpel. Spot reduction, akylation,
tryptic digestion, and mass spectrometric analysis were
performed at McGill University and Genome Québec
Innovation Centre (Montréal, Québec, Canada). Excised
spots were subjected to reduction, cysteine-alkylation
and in-gel tryptic digestion using an automated Mas-
sPrep Workstation (Micromass UK Ltd., Wythenshawe,
Manchester, UK) and a protocol previously described by
Wasiak et al. (2002) [61]. Extracted peptides were then
subjected to LC-MS/MS. First, peptides were injected
into a 300 μm×5m mZ o r b a xC 1 8t r a p p i n gc o l u m n
(Agilent Technologies, Mississauga, Ontario, Canada)
and peptides were subsequently resolved on a 10 cm ×
75 micron PicoFrit column (New Objective, Inc.,
Woburn, Massachusetts, USA) containing C18 packing
( B i o B a s i c ,I n c . ,M a r k h a m ,O n t a r i o ,C a n a d a ) .P e p t i d e s
were eluted from the column with a 15 min gradient of
10-95% acetonitrile (v/v) containing 0.1% formic acid (v/
v) at a flow rate of 200 nl/min using an Agilent 1100
series NanoHPLC system (Agilent Technologies). Eluted
peptides were electrosprayed as they exited the column.
Mass spectrometric data were acquired on a QTRAP
4000 (Applied Biosystems, Streetsville, ON, Canada)
using the Information Dependent Analysis feature of
Analyst 1.4.1 software (Applied Biosystems). Briefly, up
to three double, triple or quadruple charged ions of
intensity greater than 2 × 10
6 counts per sec from each
enhanced-MS survey scan were selected for passage into
a collision cell. Collision-induced dissociation was facili-
tated by collision with nitrogen gas; fragment ions were
trapped in quadrupole (Q)3 and scanned. Three
enhanced-product ion scans at a speed of 4000 atomic
mass unit/sec from 70 to 1700 m/z were averaged for
each selected precursor ion.
The tandem mass spectrometry raw data were trans-
ferred from the QTrap 4000 linear ion trap mass spec-
trometer to a server and automatically manipulated for
generation of peak lists by employing the Distiller ver-
sion 2.1.0.0 software http://www.matrixscience.com/dis-
tiller.html. The peak-listed data were then searched
against the National Center for Biotechnology Informa-
tion non-redundant database ftp://ftp.ncbi.nlm.nih.gov/
blast/db/ downloaded October 6, 2008) using the Mas-
cot search engine version 2.1.04 http://www.
matrixscience.com. The search was limited to the Mam-
malia taxonomy (Taxonomy ID 40674; 707975
sequences; 279723342 residues).
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Cytokines and Haptoglobin
The cytokine responses for each subject was assessed
using the estimated area under the curve described by
the change in response from days 1-6 compared to base-
line. All data points were adjusted for baseline values by
and subtracting day 0 readouts. These values were then
log-transformed prior to analysis in order to stabilize
the variance. The general linear model procedure was
used to perform a statistical analysis of these estimates
in addition to the change in response from the baseline
(day 0) for days 14 and 21 pi, using SAS (SAS Institute
Inc., Cary, North Carolina, USA). The Tukey-Kramer
adjustment was used to perform pair-wise comparisons
of the 3 treatments. Data are presented as the least
square mean of the log-transformed values ± standard
error of the mean. For haptoglobin, repeated measure-
ments taken over the course of 24 hours were analyzed
using mixed models which included the 3 treatment
groups as well the interaction between time and group,
according to the method described by Wang and Goo-
newardene (2004) [62]. Changes were determined using
day 0 as baseline values. The fixed effects were the 3
treatment groups, days and the interaction between
treatment and day, and subject within treatment group
w a si n c l u d e da sar a n d o me f f e c ti nt h em o d e l .T h e
MIXED procedure from SAS (SAS Institute Inc.) was
used for analysis. Linear and quadratic orthogonal poly-
nomial contrasts over time were used to assess differ-
ences in the responses between treatment groups. Data
are presented as the least square mean of the log-trans-
formed values ± standard error of the mean.
Milk proteomics
The experimental design was a completely randomized
design with three treatments of S. aureus and repeated
measurements for each subject at days 0, 2 and 14. All
raw values (spot intensity) were log transformed in
order to stabilize the variances, and baseline (day 0)
values were subtracted from days 2 and 14. The general
linear model (GLM) procedure was used to assess differ-
ential expression of each protein spot between treatment
groups on days 2 and 14 pi, relative to the average of
day 0 values using SAS (SAS Institute Inc., Cary, NC,
USA). Multiple comparisons between the 3 treatment
groups were performed using Tukey-Kramer’s adjust-
ment. P-values from each comparison were then cor-
rected based on the false discovery rate (FDR)
adjustment using the MULTTEST procedure. Data are
presented as the least square mean of the log trans-
formed values ± standard error of the mean.
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